Mean Platelet Volume (MPV) is a routine blood test result that reports the average size of your platelets (tiny blood cells that help stop bleeding by forming clots). MPV is typically calculated by an automated blood analyzer as part of a complete blood count (CBC) and is interpreted alongside the platelet count and other CBC values.

Platelets are made in the bone marrow and released into the bloodstream. In general, larger platelets are often younger platelets and may be more active. That means MPV can give clues about platelet production and overall bone marrow function—for example, whether the body is making platelets quickly to replace ones that are being used up or destroyed.

In plain language, MPV helps answer: “Are my platelets mostly small/older or large/younger?” A higher MPV can suggest increased platelet turnover (your body producing and releasing larger, younger platelets), while a lower MPV can suggest reduced platelet production or smaller platelets. Importantly, MPV by itself does not diagnose a specific condition. Doctors interpret MPV together with your platelet count, symptoms, medical history, and sometimes a peripheral blood smear to evaluate blood health and possible clotting disorders or bleeding tendencies.

MPV is most often reviewed when you have a CBC, especially if your platelet count is abnormal or you have symptoms that could be related to bleeding or clotting. Your clinician may consider MPV to better understand platelet size, platelet activity, and whether changes are more likely due to decreased production in the bone marrow or increased consumption/destruction in the bloodstream.

Common reasons your doctor may order or review MPV include:

Symptoms of bleeding such as easy bruising, frequent nosebleeds, bleeding gums, prolonged bleeding from cuts, unusually heavy menstrual bleeding, or tiny red-purple skin spots (petechiae).

Symptoms or risk of clotting such as unexplained swelling or pain in a leg (possible DVT), chest pain or shortness of breath (possible pulmonary embolism), or a history of heart attack or stroke—especially when combined with other blood tests and risk factors.

Abnormal platelet count found on routine testing: Low platelets (thrombocytopenia) may prompt a closer look at MPV to help distinguish decreased platelet production vs. increased destruction/consumption. High platelets (thrombocytosis) may be evaluated with MPV to support assessment of reactive causes (like inflammation) versus bone marrow-related causes.

Monitoring known conditions affecting hematology and bone marrow function, including after infections, inflammatory conditions, autoimmune disease flares, major surgery, or certain medications that can affect platelets.

Follow-up testing when there is concern for a platelet disorder: MPV may be reviewed along with platelet distribution width (PDW), other CBC indices, and sometimes specialized tests depending on the situation.

• Thrombocytopenia (low platelet count), including immune thrombocytopenia (ITP)
• Thrombocytosis (high platelet count), including reactive thrombocytosis and essential thrombocythemia
• Myeloproliferative neoplasms (bone marrow disorders affecting blood cell production)
• Aplastic anemia and other causes of bone marrow suppression or failure
• Iron deficiency anemia (can be associated with elevated platelets in some cases)
• Inflammatory and infectious conditions that affect platelet production/activation
• Disseminated intravascular coagulation (DIC) and other consumption-related clotting disorders
• Cardiovascular disease risk states where platelet activation may be relevant (interpreted with other clinical data)
• Inherited platelet function/size disorders (less common; may involve abnormal platelet size and bleeding)

• Evaluating overall blood health as part of a complete blood count (CBC) and routine wellness screening
• Supporting assessment of bleeding or bruising concerns by adding context to platelet count and function
• Monitoring bone marrow function and platelet production during or after illness, inflammation, or certain treatments
• Helping clinicians assess clotting risk factors in the broader context of cardiovascular health (alongside other labs and clinical findings)
• Tracking trends over time when platelet counts fluctuate (e.g., follow-up of thrombocytopenia or thrombocytosis)